Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xavier Rebillard

Showing results (31-40 of 65) with videos related to

Pageof 7
Sort By:
Clinical and Translational Medicine|May 19, 2015
Serum Matrix Metalloproteinase-7 is an independent prognostic biomarker in advanced bladder cancerMounira El Demery, Gaiané Demirdjian-Sarkissian, Simon Thezenas, et al.
Urology|October 12, 2016
Technique of Injection of Hyaluronic Acid as a Prostatic Spacer and Fiducials Before Hypofractionated External Beam Radiotherapy for Prostate CancerRomain Boissier, Corina Udrescu, Xavier Rebillard, et al.
Clinical Chemistry|July 26, 2005
Detection of circulating prostate-specific antigen-secreting cells in prostate cancer patientsCatherine Alix-Panabières, Xavier Rebillard, Jean-Paul Brouillet, et al.
Cancer Medicine|September 24, 2017
Nonsteroidal anti-inflammatory drugs (NSAIDs) and prostate cancer risk: results from the EPICAP studySolene Doat, Sylvie Cénée, Brigitte Trétarre, et al.
ISRN Urology|May 9, 2012
Three Years of Salvage IMRT for Prostate Cancer: Results of the Montpellier Cancer CenterOlivier Riou, Pascal Fenoglietto, Benoit Laliberté, et al.
Drug Design, Development and Therapy|September 19, 2017
Radium 223 dichloride for prostate cancer treatmentEmmanuel Deshayes, Mathieu Roumiguie, Constance Thibault, et al.
International Journal of Cancer|April 27, 2018
Prostatitis, other genitourinary infections and prostate cancer risk: Influence of non-steroidal anti-inflammatory drugs? Results from the EPICAP studySolène Doat, Miguelle Marous, Xavier Rebillard, et al.
BJU International|March 22, 2021
Artificial intelligence to improve cytology performances in bladder carcinoma detection: results of the VisioCyt testThierry Lebret, Geraldine Pignot, Marc Colombel, et al.
Annales De Pathologie|December 17, 2008
[The uropathological standardized reports]Vincent Molinié, Marc de Fromont, Agnès Lesourd, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|December 25, 2007
[Standardized calculation in the pathology of urologic cancers]Marc de Fromont, Agnès Lesourd, Catherine Mazerolles, et al.
Pageof 7

Showing results (31-40 of 65) with videos related to

Sort By:
Pageof 7
Clinical and Translational Medicine|May 19, 2015
Serum Matrix Metalloproteinase-7 is an independent prognostic biomarker in advanced bladder cancerMounira El Demery, Gaiané Demirdjian-Sarkissian, Simon Thezenas, et al.
Urology|October 12, 2016
Technique of Injection of Hyaluronic Acid as a Prostatic Spacer and Fiducials Before Hypofractionated External Beam Radiotherapy for Prostate CancerRomain Boissier, Corina Udrescu, Xavier Rebillard, et al.
Clinical Chemistry|July 26, 2005
Detection of circulating prostate-specific antigen-secreting cells in prostate cancer patientsCatherine Alix-Panabières, Xavier Rebillard, Jean-Paul Brouillet, et al.
Cancer Medicine|September 24, 2017
Nonsteroidal anti-inflammatory drugs (NSAIDs) and prostate cancer risk: results from the EPICAP studySolene Doat, Sylvie Cénée, Brigitte Trétarre, et al.
ISRN Urology|May 9, 2012
Three Years of Salvage IMRT for Prostate Cancer: Results of the Montpellier Cancer CenterOlivier Riou, Pascal Fenoglietto, Benoit Laliberté, et al.
Drug Design, Development and Therapy|September 19, 2017
Radium 223 dichloride for prostate cancer treatmentEmmanuel Deshayes, Mathieu Roumiguie, Constance Thibault, et al.
International Journal of Cancer|April 27, 2018
Prostatitis, other genitourinary infections and prostate cancer risk: Influence of non-steroidal anti-inflammatory drugs? Results from the EPICAP studySolène Doat, Miguelle Marous, Xavier Rebillard, et al.
BJU International|March 22, 2021
Artificial intelligence to improve cytology performances in bladder carcinoma detection: results of the VisioCyt testThierry Lebret, Geraldine Pignot, Marc Colombel, et al.
Annales De Pathologie|December 17, 2008
[The uropathological standardized reports]Vincent Molinié, Marc de Fromont, Agnès Lesourd, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|December 25, 2007
[Standardized calculation in the pathology of urologic cancers]Marc de Fromont, Agnès Lesourd, Catherine Mazerolles, et al.
Pageof 7